Apolipoproteins B and A1 in Ischemic Stroke Subtypes

Area of Science:

• Biochemistry
• Neurology
• Cardiovascular Medicine

Background:

• Elevated serum apolipoprotein B (ApoB) and ApoB/A1 ratio are linked to ischemic stroke and intracranial atherosclerosis.
• Understanding ApoB and ApoA1 roles in stroke subtypes and atherosclerosis location is crucial.

Purpose of the Study:

• To assess serum ApoB, ApoA1, and ApoB/A1 ratio in relation to ischemic stroke subtypes.
• To evaluate these markers concerning large artery atherosclerosis location (intracranial vs. extracranial).

Main Methods:

• Evaluated statin-naïve adult ischemic stroke patients in southern India.
• Compared mean serum ApoB, ApoA1, and ApoB/A1 ratios across stroke subtypes (intracranial atherosclerosis, extracranial atherosclerosis, small vessel disease, cardioembolism).
• Secondary analysis compared ApoB/A1 ratios in moderate-severe intracranial vs. extracranial atherosclerotic disease.

Main Results:

• No significant differences in serum ApoB, ApoA1, or ApoB/A1 ratio were found among ischemic stroke subtypes.
• No significant differences were observed in these serum markers between patients with moderate-severe intracranial and extracranial atherosclerotic disease.

Conclusions:

• Serum ApoB and ApoA1 levels do not appear to differ significantly between ischemic stroke subtypes.
• Further studies are required to validate these findings and elucidate the precise relationship between serum apolipoproteins and stroke etiology.